H

Hemostatics

10 employees

Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling hemorrhagic conditions.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Pharmaceutical
Hereditary cerebral hemorrhage with amyloidosis
Bleeding
haemorrhage
Accidents
Drug Discovery
healthcare
Health Care
ICH
Osler-Weber-Rendu syndrome
Military Battlefield
Heavy menstrual bleeding
pharma
Post-partum hemorrhage
Drug Development
Trauma
Medical
Gastrointestinal bleeding

Date founded

2020

FAQ